Feasibility assessment of an ambulatory monitoring and management of chronic obstructive pulmonary disease

The George Institute for Global Health0 sites20 target enrollmentStarted: May 12, 2021Last updated: May 17, 2021

Conditions

Trial Snapshot

No summary available.

•1. Evidence of spirometrically confirmed airflow obstruction, defined as a post-bronchodilator FEV1/FVC ratio <0.7 and post-bronchodilator FEV1 between 30% and 70% predicted, recorded within 1 year of screening
•2. Report one or more of the following symptoms within the preceding two weeks: shortness of breath, chronic cough and sputum
•3. Hospitalisation for worsening COPD (exacerbation) on one or more occasions in the two years prior to commencement of study procedures
•4. Be ambulatory and self-caring at the time of recruitment

•1. Have experienced an exacerbation in the 30 days prior to screening
•2. In the opinion of the investigator will not complete the study or adhere to the intervention
•3. In the opinion of the investigator, have an inadequate mastery of English to communicate with study staff
•4. Is unable to independently provide consent

Sponsor